APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pimavanserin Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pimavanserin Drugs Market Outlook and Growth Opportunities 2026

Report ID 174025770427 December 2025198 pages

Choose your research edition.

Industry ResearchPimavanserin Drugs Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Pimavanserin Drugs Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Pimavanserin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pimavanserin Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pimavanserin Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pimavanserin Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pimavanserin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pimavanserin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pimavanserin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pimavanserin Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pimavanserin Drugs market include Zydus Pharmaceuticals, MSN Laboratories, Hetero Labs and Acadia Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pimavanserin Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pimavanserin Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pimavanserin Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pimavanserin Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Pimavanserin Drugs Segment by Company

Zydus Pharmaceuticals

MSN Laboratories

Hetero Labs

Acadia Pharmaceuticals

Pimavanserin Drugs Segment by Type

Tablets

Capsules

Pimavanserin Drugs Segment by Application

Hospital and Clinic

Pharmacy

Other

Pimavanserin Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pimavanserin Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pimavanserin Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pimavanserin Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Pimavanserin Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pimavanserin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pimavanserin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pimavanserin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pimavanserin Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pimavanserin Drugs industry.

Chapter 3: Detailed analysis of Pimavanserin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pimavanserin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pimavanserin Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pimavanserin Drugs Industry Trends Table 2. Pimavanserin Drugs Industry Drivers Table 3. Pimavanserin Drugs Industry Opportunities and Challenges Table 4. Pimavanserin Drugs Industry Restraints Table 5. Global Pimavanserin Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pimavanserin Drugs Revenue Share by Company (2021-2026) Table 7. Global Pimavanserin Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pimavanserin Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Pimavanserin Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pimavanserin Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pimavanserin Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Pimavanserin Drugs Company, Product Type & Application Table 13. Global Pimavanserin Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pimavanserin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Global Pimavanserin Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pimavanserin Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Pimavanserin Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Pimavanserin Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Pimavanserin Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Pimavanserin Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pimavanserin Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pimavanserin Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pimavanserin Drugs Sales Value Share by Type (2021-2026) Table 28. Global Pimavanserin Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Other Table 32. Global Pimavanserin Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pimavanserin Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Pimavanserin Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Pimavanserin Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Pimavanserin Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Pimavanserin Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pimavanserin Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pimavanserin Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pimavanserin Drugs Sales Value Share by Application (2021-2026) Table 41. Global Pimavanserin Drugs Sales Value Share by Application (2027-2032) Table 42. Global Pimavanserin Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pimavanserin Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Pimavanserin Drugs Sales Market Share by Region (2021-2026) Table 45. Global Pimavanserin Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Pimavanserin Drugs Sales Market Share by Region (2027-2032) Table 47. Global Pimavanserin Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pimavanserin Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pimavanserin Drugs Sales Value Share by Region (2021-2026) Table 50. Global Pimavanserin Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pimavanserin Drugs Sales Value Share by Region (2027-2032) Table 52. Global Pimavanserin Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Pimavanserin Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Pimavanserin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Pimavanserin Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pimavanserin Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Pimavanserin Drugs Sales Market Share by Country (2021-2026) Table 58. Global Pimavanserin Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Pimavanserin Drugs Sales Market Share by Country (2027-2032) Table 60. Global Pimavanserin Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pimavanserin Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Pimavanserin Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pimavanserin Drugs Sales Value Market Share by Country (2027-2032) Table 64. Zydus Pharmaceuticals Company Information Table 65. Zydus Pharmaceuticals Business Overview Table 66. Zydus Pharmaceuticals Pimavanserin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Zydus Pharmaceuticals Pimavanserin Drugs Product Portfolio Table 68. Zydus Pharmaceuticals Recent Development Table 69. MSN Laboratories Company Information Table 70. MSN Laboratories Business Overview Table 71. MSN Laboratories Pimavanserin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. MSN Laboratories Pimavanserin Drugs Product Portfolio Table 73. MSN Laboratories Recent Development Table 74. Hetero Labs Company Information Table 75. Hetero Labs Business Overview Table 76. Hetero Labs Pimavanserin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hetero Labs Pimavanserin Drugs Product Portfolio Table 78. Hetero Labs Recent Development Table 79. Acadia Pharmaceuticals Company Information Table 80. Acadia Pharmaceuticals Business Overview Table 81. Acadia Pharmaceuticals Pimavanserin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Acadia Pharmaceuticals Pimavanserin Drugs Product Portfolio Table 83. Acadia Pharmaceuticals Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Pimavanserin Drugs Distributors List Table 87. Pimavanserin Drugs Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Pimavanserin Drugs Product Image Figure 2. Global Pimavanserin Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pimavanserin Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pimavanserin Drugs Sales (2021-2032) & (K Units) Figure 5. Global Pimavanserin Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pimavanserin Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Pimavanserin Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pimavanserin Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pimavanserin Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Pimavanserin Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pimavanserin Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pimavanserin Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Other Image Figure 20. Global Pimavanserin Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pimavanserin Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pimavanserin Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Pimavanserin Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pimavanserin Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pimavanserin Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Pimavanserin Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Pimavanserin Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pimavanserin Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pimavanserin Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pimavanserin Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pimavanserin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pimavanserin Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pimavanserin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pimavanserin Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pimavanserin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pimavanserin Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pimavanserin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pimavanserin Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pimavanserin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pimavanserin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pimavanserin Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pimavanserin Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Zydus Pharmaceuticals
  • MSN Laboratories
  • Hetero Labs
  • Acadia Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pimavanserin Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Pimavanserin Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Pimavanserin Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pimavanserin Drugs Market Dynamics
  1. 2.1 Pimavanserin Drugs Industry Trends
  2. 2.2 Pimavanserin Drugs Industry Drivers
  3. 2.3 Pimavanserin Drugs Industry Opportunities and Challenges
  4. 2.4 Pimavanserin Drugs Industry Restraints
3 Pimavanserin Drugs Market by Company
  1. 3.1 Global Pimavanserin Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Pimavanserin Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Pimavanserin Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Pimavanserin Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Pimavanserin Drugs Company Ranking (2024-2026)
  6. 3.6 Global Pimavanserin Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Pimavanserin Drugs Company Product Type and Application
  8. 3.8 Global Pimavanserin Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pimavanserin Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pimavanserin Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pimavanserin Drugs Market by Type
  1. 4.1 Pimavanserin Drugs Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Pimavanserin Drugs Sales Volume by Type
  5. 4.2.1 Global Pimavanserin Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pimavanserin Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pimavanserin Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pimavanserin Drugs Sales Value by Type
  9. 4.3.1 Global Pimavanserin Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pimavanserin Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pimavanserin Drugs Sales Value Share by Type (2021-2032)
5 Pimavanserin Drugs Market by Application
  1. 5.1 Pimavanserin Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Pimavanserin Drugs Sales Volume by Application
  6. 5.2.1 Global Pimavanserin Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pimavanserin Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pimavanserin Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pimavanserin Drugs Sales Value by Application
  10. 5.3.1 Global Pimavanserin Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pimavanserin Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pimavanserin Drugs Sales Value Share by Application (2021-2032)
6 Pimavanserin Drugs Regional Sales and Value Analysis
  1. 6.1 Global Pimavanserin Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pimavanserin Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Pimavanserin Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Pimavanserin Drugs Sales by Region (2027-2032)
  5. 6.3 Global Pimavanserin Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pimavanserin Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pimavanserin Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pimavanserin Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Pimavanserin Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pimavanserin Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Pimavanserin Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pimavanserin Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Pimavanserin Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pimavanserin Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pimavanserin Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pimavanserin Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Pimavanserin Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pimavanserin Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pimavanserin Drugs Sales Value Share by Country, 2025 VS 2032
7 Pimavanserin Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Pimavanserin Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pimavanserin Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pimavanserin Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Pimavanserin Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Pimavanserin Drugs Sales by Country (2027-2032)
  6. 7.4 Global Pimavanserin Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pimavanserin Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pimavanserin Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pimavanserin Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pimavanserin Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pimavanserin Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zydus Pharmaceuticals
  2. 8.1.1 Zydus Pharmaceuticals Company Information
  3. 8.1.2 Zydus Pharmaceuticals Business Overview
  4. 8.1.3 Zydus Pharmaceuticals Pimavanserin Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zydus Pharmaceuticals Pimavanserin Drugs Product Portfolio
  6. 8.1.5 Zydus Pharmaceuticals Recent Developments
  7. 8.2 MSN Laboratories
  8. 8.2.1 MSN Laboratories Company Information
  9. 8.2.2 MSN Laboratories Business Overview
  10. 8.2.3 MSN Laboratories Pimavanserin Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MSN Laboratories Pimavanserin Drugs Product Portfolio
  12. 8.2.5 MSN Laboratories Recent Developments
  13. 8.3 Hetero Labs
  14. 8.3.1 Hetero Labs Company Information
  15. 8.3.2 Hetero Labs Business Overview
  16. 8.3.3 Hetero Labs Pimavanserin Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hetero Labs Pimavanserin Drugs Product Portfolio
  18. 8.3.5 Hetero Labs Recent Developments
  19. 8.4 Acadia Pharmaceuticals
  20. 8.4.1 Acadia Pharmaceuticals Company Information
  21. 8.4.2 Acadia Pharmaceuticals Business Overview
  22. 8.4.3 Acadia Pharmaceuticals Pimavanserin Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Acadia Pharmaceuticals Pimavanserin Drugs Product Portfolio
  24. 8.4.5 Acadia Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pimavanserin Drugs Value Chain Analysis
  2. 9.1.1 Pimavanserin Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pimavanserin Drugs Sales Mode & Process
  6. 9.2 Pimavanserin Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pimavanserin Drugs Distributors
  9. 9.2.3 Pimavanserin Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst